Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials-Reference-Cited by-同舟云学术

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials

Published:2009-08 Issue:8 Volume:31 Page:1844-1855
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Findling Robert L.,Wigal Sharon B.,Bukstein Oscar G.,Boellner Samuel W.,Abikoff Howard B.,Turnbow John M.,Civil Rich

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents;Pelham;Ambul Pediatr.,2007

2. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study;Barkley;J Am Acad Child Adolesc Psychiatry,1990

3. Attention-deficit/hyperactivity disorder: A selective overview;Biederman;Biol Psychiatry,2005

4. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication;Kessler;Am J Psychiatry,2006

5. Attention-deficit/hyperactivity disorder among adolescents: A review of the diagnosis, treatment, and clinical implications;Wolraich;Pediatrics,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary diagnosis and treatment of conduct disorder in youth;Expert Review of Neurotherapeutics;2023-10-19

2. Cardiovascular Considerations for Stimulant Class Medications;Child and Adolescent Psychiatric Clinics of North America;2022-07

3. Methylphenidate-Associated Syncope;Journal of Clinical Psychopharmacology;2022-06-11

4. Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to <6 Years;Journal of the American Academy of Child & Adolescent Psychiatry;2022-01

5. Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients;CNS Spectrums;2021-04-12